Literature DB >> 2271634

Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.

S R Campion1, R K Matsunami, D A Engler, S K Niyogi.   

Abstract

Eight analogues of human epidermal growth factor (hEGF) having specific amino acid substitutions in the beta-sheet structure (residues 19-31) of the amino-terminal domain were generated by site-directed mutagenesis. Affinity of the epidermal growth factor (EGF) receptor for each of these mutant hEGF analogues was measured by both radioreceptor competition binding and receptor tyrosine kinase stimulation assays. The relative binding affinities obtained by these two methods were generally in agreement for each hEGF species. The results indicate that hydrophobic residues on the exposed surface of the beta-sheet structure of the amino-terminal domain of hEGF have an important role in the formation of the active EGF-receptor complex. The substitution of hydrophobic amino acid residues, Val-19----Gly, Met-21----Thr, Ile-23----Thr, and Leu-26----Gly, resulted in decreased binding affinity, with the most severe reductions observed with the last two mutants. The mutations Ala-25----Val and Lys-28----Arg introduced amino acid residues resulting in slightly increased receptor binding affinity. Similar to previous results with acidic residues in this region [Engler, D.A., Matsunami, R.K., Campion, S.R., Stringer, C.D., Stevens, A., & Niyogi, S.K. (1988) J. Biol. Chem. 263, 12384-12390], removal of the positive charge in the Lys-28----Leu substitution had almost no effect on binding affinity, indicating the lack of any absolute requirement for ionic interactions at this site. Substitution of Tyr-22, which resulted in decreased receptor binding affinity, provides further indication of the importance of aromatic residues in this region of the molecule, as found earlier with Tyr-29 (cf. reference above).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271634     DOI: 10.1021/bi00494a032

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Structure-function studies of mEGF: probing the type I beta-turn between residues 25 and 26.

Authors:  C C Lester; B Wang; R Wu; H A Scheraga
Journal:  J Protein Chem       Date:  1995-11

2.  Genetically engineered block copolymers: influence of the length and structure of the coiled-coil blocks on hydrogel self-assembly.

Authors:  Chunyu Xu; Jindrich Kopecek
Journal:  Pharm Res       Date:  2007-08-23       Impact factor: 4.200

3.  Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis.

Authors:  Richard A Stein; James V Staros
Journal:  BMC Evol Biol       Date:  2006-10-06       Impact factor: 3.260

4.  Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4.

Authors:  K Nagata; D Kohda; H Hatanaka; S Ichikawa; S Matsuda; T Yamamoto; A Suzuki; F Inagaki
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

5.  Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain.

Authors:  Hannes H Loeffler; Martyn D Winn
Journal:  Proteins       Date:  2013-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.